TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
1 of Canopy Growth Corp.’s Biggest Competitive Advantages Just Went Up in Smoke
Investing
Aurora Cannabis Inc. to Acquire CanniMed Therapeutics Inc. in Friendly Deal
Investing
Will This Week See a 15% Pullback in Marijuana Stocks?
Investing
Aurora Cannabis Inc. vs. CanniMed Therapeutics Inc.: I’m Not Surprised
Investing
Are Marijuana Stocks Losing Their Shine for Speculative Money?
Energy Stocks
This Stock Is on Sale Today With Massive Upside Tomorrow
Investing
Marijuana Stocks: Is Canopy Growth Corp. a Buy Under $40?
Investing
Canopy Growth Corp. Is up 193% in 3 Months. Is More Coming?
Investing
The Latest Twist in Aurora Cannabis Inc.’s Pursuit of CanniMed Therapeutics Inc.
Investing
Canadian Regulators Are Sucking All the Fun Out of Legal Cannabis
